Distribution of BCR::ABL1 transcript types and response to therapy in pediatric patients with chronic myeloid leukemia

被引：0
|
作者：
Seiser, E. [1 ]
Behrens, Y. L. [2 ]
Lukat, S. [3 ]
Metzler, M. [3 ]
Krumbholz, M. [3 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Erlangen, Germany
[2] Hannover Med Sch, Hannover, Germany
[3] Univ Hosp Erlangen, Erlangen, Germany
来源：
KLINISCHE PADIATRIE | 2024年 / 236卷 / 03期
关键词：
D O I：
10.1055/s-0044-1786623
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
0072
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [31] Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia
    Gupta, Manu
    Milani, Lili
    Hermansson, Monica
    Simonsson, Bengt
    Markevarn, Berit
    Syvdnen, Ann Christine
    Barbany, Gisela
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 366 (03) : 848 - 851
  • [32] Human BCR/ABL1 induces chronic myeloid leukemia-like disease in zebrafish
    Xu, Mengchang
    Ye, Yin
    Ye, Zhi'an
    Xu, Song'en
    Liu, Wei
    Xu, Jin
    Zhang, Yiyue
    Liu, Qifa
    Huang, Zhibin
    Zhang, Wenqing
    HAEMATOLOGICA, 2020, 105 (03) : 674 - 686
  • [33] BCR-ABL fusion gene and BCR-ABL transcript -: Correlation with response to therapy in Chronic Myeloid Leukaemia.
    Geraldes, C
    Gonçalves, AC
    Santos, P
    Tavares, P
    Teixeira, A
    BLOOD, 2005, 106 (11) : 297B - 297B
  • [34] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
    Krumbholz, Manuela
    Karl, Matthias
    Tauer, Josephine T.
    Thiede, Christian
    Rascher, Wolfgang
    Suttorp, Meinolf
    Metzler, Markus
    GENES CHROMOSOMES & CANCER, 2012, 51 (11): : 1045 - 1053
  • [35] Importance of BCR/ABL1 Transcript Type in CML
    Cross, Nicholas C. P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S20 - S22
  • [36] Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
    Martinelli, G
    Iacobucci, I
    Rosti, G
    Pane, F
    Amabile, M
    Castagnetti, F
    Cilloni, D
    Soverini, S
    Testoni, N
    Specchia, G
    Merante, S
    Zaccaria, A
    Frassoni, F
    Saglio, G
    Baccarani, M
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 495 - 502
  • [37] Prognostic Significance of Transcript-Type BCR-ABL1 in Chronic Myeloid Leukemia
    Molica, Matteo
    Abruzzese, Elisabetta
    Breccia, Massimo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [38] Sensitivity to Imatinib In BCR-ABL1-Positive Chronic Myeloid Leukemia Cells Depends on the Presence of Normal ABL1
    Dasgupta, Yashodhara
    Virgili, Anna
    Koptyra, Mateusz
    Nacheva, Elisabeth P.
    Skorski, Tomasz
    BLOOD, 2010, 116 (21) : 1394 - 1394
  • [39] The efficacy of TKI in patients with different BCR/ABL transcript types of chronic myeloid leukemia: a systematic review and meta-analysis
    Wang, Yanyan
    Du, Qiancheng
    Wang, Yongqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (12): : 13337 - 13347
  • [40] Triplet therapy for advanced BCR::ABL1 positive myeloid leukaemias
    Copland, Mhairi
    LANCET HAEMATOLOGY, 2024, 11 (11): : e807 - e808
12345